	Gene	Drug Name	Mechanism of Action	Drug development phase	Algorithm	GWAS
0	ROS1	entrectinib	ALK tyrosine kinase receptor inhibitor|proto-oncogene tyrosine protein kinase inhibitor	Launched	DOMINO	GCST004748
1	ROS1	PF-06463922	ALK tyrosine kinase receptor inhibitor	Launched	DOMINO	GCST004748
2	IL5	pranlukast	leukotriene receptor antagonist	Launched	DOMINO	GCST009841
3	IL2	ephedrine-(racemic)	adrenergic receptor agonist	Launched	DOMINO	GCST009841
4	PRKCQ	afimoxifene	estrogen receptor antagonist	Phase 2	dmGWAS	GCST004988
5	PRKCQ	dexfosfoserine	membrane integrity inhibitor	Preclinical	dmGWAS	GCST004988
6	PRKCQ	GSK690693	AKT inhibitor	Phase 1	dmGWAS	GCST004988
7	PRKCQ	sotrastaurin	PKC inhibitor	Phase 2	dmGWAS	GCST004988
8	PRKCQ	tamoxifen	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	dmGWAS	GCST004988
9	CDK6	abemaciclib	CDK inhibitor	Launched	dmGWAS	GCST004988
10	CDK6	alvocidib	CDK inhibitor	Phase 2	dmGWAS	GCST004988
11	CDK6	AMG-925	CDK inhibitor|FLT3 inhibitor	Phase 1	dmGWAS	GCST004988
12	CDK6	apigenin	casein kinase inhibitor|cell proliferation inhibitor	Preclinical	dmGWAS	GCST004988
13	CDK6	AT-7519	CDK inhibitor	Phase 2	dmGWAS	GCST004988
14	CDK6	chrysin	breast cancer resistance protein inhibitor	Phase 1	dmGWAS	GCST004988
15	CDK6	fisetin	Aurora kinase inhibitor	Preclinical	dmGWAS	GCST004988
16	CDK6	palbociclib	CDK inhibitor	Launched	dmGWAS	GCST004988
17	CDK6	RGB-286638	CDK inhibitor	Phase 1	dmGWAS	GCST004988
18	CDK6	ribociclib	CDK inhibitor	Launched	dmGWAS	GCST004988
19	FDPS	alendronate	bone resorption inhibitor	Launched	dmGWAS	GCST004988
20	FDPS	ibandronate	bone resorption inhibitor	Launched	dmGWAS	GCST004988
21	FDPS	minodronic-acid	bone resorption inhibitor	Launched	dmGWAS	GCST004988
22	FDPS	neridronic-acid	bone resorption inhibitor	Launched	dmGWAS	GCST004988
23	FDPS	pamidronate	bone resorption inhibitor	Launched	dmGWAS	GCST004988
24	FDPS	risedronate	osteoclast inhibitor	Launched	dmGWAS	GCST004988
25	FDPS	zoledronic-acid	bone resorption inhibitor	Launched	dmGWAS	GCST004988
26	CYP3A4	alclometasone-dipropionate	glucocorticoid receptor agonist	Launched	dmGWAS	GCST004988
27	CYP3A4	ambroxol	sodium channel blocker	Launched	dmGWAS	GCST004988
28	CYP3A4	arbidol	cytochrome P450 inhibitor	Launched	dmGWAS	GCST004988
29	CYP3A4	benfluralin		Phase 3	dmGWAS	GCST004988
30	CYP3A4	BMS-536924	IGF-1 inhibitor	Preclinical	dmGWAS	GCST004988
31	CYP3A4	brivanib	FGFR inhibitor|VEGFR inhibitor	Phase 3	dmGWAS	GCST004988
32	CYP3A4	cefradine	bacterial cell wall synthesis inhibitor	Launched	dmGWAS	GCST004988
33	CYP3A4	clarithromycin	bacterial 50S ribosomal subunit inhibitor	Launched	dmGWAS	GCST004988
34	CYP3A4	clotrimazole	cytochrome P450 inhibitor|imidazoline receptor ligand	Launched	dmGWAS	GCST004988
35	CYP3A4	cobicistat	cytochrome P450 inhibitor	Launched	dmGWAS	GCST004988
36	CYP3A4	curcumin	cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor	Launched	dmGWAS	GCST004988
37	CYP3A4	cyclophosphamide	DNA alkylating agent	Launched	dmGWAS	GCST004988
38	CYP3A4	dapivirine	non-nucleoside reverse transcriptase inhibitor	Phase 3	dmGWAS	GCST004988
39	CYP3A4	darunavir	HIV protease inhibitor	Launched	dmGWAS	GCST004988
40	CYP3A4	deferasirox	chelating agent	Launched	dmGWAS	GCST004988
41	CYP3A4	delanzomib	proteasome inhibitor	Phase 1/Phase 2	dmGWAS	GCST004988
42	CYP3A4	delavirdine	non-nucleoside reverse transcriptase inhibitor	Launched	dmGWAS	GCST004988
43	CYP3A4	dolutegravir	HIV integrase inhibitor	Launched	dmGWAS	GCST004988
44	CYP3A4	ebastine	histamine receptor antagonist	Launched	dmGWAS	GCST004988
45	CYP3A4	efavirenz	HIV protease inhibitor	Launched	dmGWAS	GCST004988
46	CYP3A4	enilconazole	sterol demethylase inhibitor	Launched	dmGWAS	GCST004988
47	CYP3A4	erythromycin-estolate	bacterial 50S ribosomal subunit inhibitor	Launched	dmGWAS	GCST004988
48	CYP3A4	erythromycin-ethylsuccinate	cytochrome P450 inhibitor|protein synthesis inhibitor	Launched	dmGWAS	GCST004988
49	CYP3A4	etravirine	non-nucleoside reverse transcriptase inhibitor	Launched	dmGWAS	GCST004988
50	CYP3A4	GSK1070916	Aurora kinase inhibitor	Phase 1	dmGWAS	GCST004988
51	CYP3A4	ifosfamide	DNA alkylating agent	Launched	dmGWAS	GCST004988
52	CYP3A4	indinavir	HIV protease inhibitor	Launched	dmGWAS	GCST004988
53	CYP3A4	isavuconazole	cytochrome P450 inhibitor	Phase 3	dmGWAS	GCST004988
54	CYP3A4	isoniazid	FABI inhibitor	Launched	dmGWAS	GCST004988
55	CYP3A4	methoxsalen	DNA synthesis inhibitor	Launched	dmGWAS	GCST004988
56	CYP3A4	metronidazole	DNA inhibitor	Launched	dmGWAS	GCST004988
57	CYP3A4	ML3403	MAP kinase inhibitor	Preclinical	dmGWAS	GCST004988
58	CYP3A4	nafcillin	bacterial cell wall synthesis inhibitor	Launched	dmGWAS	GCST004988
59	CYP3A4	nefazodone	adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor	Withdrawn	dmGWAS	GCST004988
60	CYP3A4	nelfinavir	HIV protease inhibitor	Launched	dmGWAS	GCST004988
61	CYP3A4	nevirapine	non-nucleoside reverse transcriptase inhibitor	Launched	dmGWAS	GCST004988
62	CYP3A4	palmatine-chloride	dopamine synthesis inhibitor	Preclinical	dmGWAS	GCST004988
63	CYP3A4	PF-4981517	cytochrome P450 inhibitor	Preclinical	dmGWAS	GCST004988
64	CYP3A4	posaconazole	sterol demethylase inhibitor	Launched	dmGWAS	GCST004988
65	CYP3A4	rifapentine	RNA polymerase inhibitor	Launched	dmGWAS	GCST004988
66	CYP3A4	ritonavir	HIV protease inhibitor	Launched	dmGWAS	GCST004988
67	CYP3A4	saquinavir	HIV protease inhibitor	Launched	dmGWAS	GCST004988
68	CYP3A4	SB-203580	p38 MAPK inhibitor	Preclinical	dmGWAS	GCST004988
69	CYP3A4	simeprevir	HCV inhibitor	Launched	dmGWAS	GCST004988
70	CYP3A4	SKF-96365	calcium channel blocker	Preclinical	dmGWAS	GCST004988
71	CYP3A4	sulfanilamide	carbonic anhydrase inhibitor	Launched	dmGWAS	GCST004988
72	CYP3A4	telithromycin	bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor	Launched	dmGWAS	GCST004988
73	CYP3A4	thiotepa	cytochrome P450 inhibitor	Launched	dmGWAS	GCST004988
74	CYP3A4	tofisopam	cytochrome P450 inhibitor|phosphodiesterase inhibitor	Launched	dmGWAS	GCST004988
75	CYP3A4	verapamil	calcium channel blocker	Launched	dmGWAS	GCST004988
76	CYP3A4	voriconazole	cytochrome P450 inhibitor	Launched	dmGWAS	GCST004988
77	CYP3A5	cobicistat	cytochrome P450 inhibitor	Launched	dmGWAS	GCST004988
78	CYP3A5	cyclophosphamide	DNA alkylating agent	Launched	dmGWAS	GCST004988
79	CYP3A5	dapivirine	non-nucleoside reverse transcriptase inhibitor	Phase 3	dmGWAS	GCST004988
80	CYP3A5	dolutegravir	HIV integrase inhibitor	Launched	dmGWAS	GCST004988
81	CYP3A5	enilconazole	sterol demethylase inhibitor	Launched	dmGWAS	GCST004988
82	CYP3A5	ifosfamide	DNA alkylating agent	Launched	dmGWAS	GCST004988
83	CYP3A5	indinavir	HIV protease inhibitor	Launched	dmGWAS	GCST004988
84	CYP3A5	nevirapine	non-nucleoside reverse transcriptase inhibitor	Launched	dmGWAS	GCST004988
85	CYP3A5	ritonavir	HIV protease inhibitor	Launched	dmGWAS	GCST004988
86	CYP3A5	telithromycin	bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor	Launched	dmGWAS	GCST004988
87	CYP3A5	voriconazole	cytochrome P450 inhibitor	Launched	dmGWAS	GCST004988
88	TUBB6	cabazitaxel	microtubule inhibitor	Launched	dmGWAS	GCST004988
89	TUBB6	colchicine	microtubule inhibitor	Launched	dmGWAS	GCST004988
90	TUBB6	docetaxel	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004988
91	TUBB6	paclitaxel	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004988
92	TUBB6	vinorelbine	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004988
93	TUBB	ABT-751	tubulin polymerization inhibitor	Phase 2	dmGWAS	GCST004988
94	TUBB	albendazole	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004988
95	TUBB	cabazitaxel	microtubule inhibitor	Launched	dmGWAS	GCST004988
96	TUBB	carbendazim	microtubule inhibitor|tubulin polymerization inhibitor	Launched	dmGWAS	GCST004988
97	TUBB	cevipabulin	microtubule stimulant|tubulin polymerization inhibitor	Phase 1	dmGWAS	GCST004988
98	TUBB	colchicine	microtubule inhibitor	Launched	dmGWAS	GCST004988
99	TUBB	CYT-997	tubulin polymerization inhibitor	Phase 2	dmGWAS	GCST004988
100	TUBB	D-64131	microtubule inhibitor	Preclinical	dmGWAS	GCST004988
101	TUBB	docetaxel	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004988
102	TUBB	dolastatin-10	tubulin polymerization inhibitor	Phase 2	dmGWAS	GCST004988
103	TUBB	epothilone-B	microtubule stabilizing agent|tubulin polymerization inhibitor	Phase 3	dmGWAS	GCST004988
104	TUBB	epothilone-D	microtubule stabilizing agent|tubulin polymerization inhibitor	Phase 2	dmGWAS	GCST004988
105	TUBB	fenbendazole	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004988
106	TUBB	flubendazole	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004988
107	TUBB	ixabepilone	microtubule stabilizing agent	Launched	dmGWAS	GCST004988
108	TUBB	mebendazole	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004988
109	TUBB	oxibendazole	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004988
110	TUBB	paclitaxel	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004988
111	TUBB	parbendazole	tubulin polymerization inhibitor	Preclinical	dmGWAS	GCST004988
112	TUBB	podophyllotoxin	microtubule inhibitor|tubulin polymerization inhibitor	Launched	dmGWAS	GCST004988
113	TUBB	verubulin	tubulin polymerization inhibitor	Phase 2	dmGWAS	GCST004988
114	TUBB	vinblastine	microtubule inhibitor|tubulin polymerization inhibitor	Launched	dmGWAS	GCST004988
115	TUBB	vincristine	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004988
116	TUBB	vindesine	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004988
117	TUBB	vinorelbine	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004988
118	TUBB	2-methoxyestradiol	hypoxia inducible factor inhibitor	Phase 2	dmGWAS	GCST004988
119	RRM2	cladribine	adenosine deaminase inhibitor|ribonucleotide reductase inhibitor	Launched	dmGWAS	GCST004988
120	RRM2	clofarabine	ribonucleotide reductase inhibitor	Launched	dmGWAS	GCST004988
121	RRM2	fludarabine	ribonucleotide reductase inhibitor	Launched	dmGWAS	GCST004988
122	RRM2	fludarabine-phosphate	ribonucleotide reductase inhibitor	Launched	dmGWAS	GCST004988
123	RRM2	gemcitabine	ribonucleotide reductase inhibitor	Launched	dmGWAS	GCST004988
124	RRM2	hydroxyurea	ribonucleotide reductase inhibitor	Launched	dmGWAS	GCST004988
125	RRM2	triapine	ribonucleotide reductase inhibitor	Phase 2	dmGWAS	GCST004988
126	PIK3CB	acalisib	PI3K inhibitor	Phase 1	dmGWAS	GCST004988
127	PIK3CB	alpelisib	PI3K inhibitor	Launched	dmGWAS	GCST004988
128	PIK3CB	AZD6482	PI3K inhibitor	Phase 1	dmGWAS	GCST004988
129	PIK3CB	AZD8186	PI3K inhibitor	Phase 1	dmGWAS	GCST004988
130	PIK3CB	BGT226	PI3K inhibitor	Phase 1/Phase 2	dmGWAS	GCST004988
131	PIK3CB	caffeine	adenosine receptor antagonist|phosphodiesterase inhibitor	Launched	dmGWAS	GCST004988
132	PIK3CB	CH5132799	PI3K inhibitor	Phase 1	dmGWAS	GCST004988
133	PIK3CB	copanlisib	PI3K inhibitor	Launched	dmGWAS	GCST004988
134	PIK3CB	duvelisib	PI3K inhibitor	Launched	dmGWAS	GCST004988
135	PIK3CB	ETP-45658	PI3K inhibitor	Preclinical	dmGWAS	GCST004988
136	PIK3CB	GDC-0941	PI3K inhibitor	Phase 2	dmGWAS	GCST004988
137	PIK3CB	GDC-0980	mTOR inhibitor|PI3K inhibitor	Phase 2	dmGWAS	GCST004988
138	PIK3CB	GSK2126458	mTOR inhibitor|PI3K inhibitor	Phase 1	dmGWAS	GCST004988
139	PIK3CB	GSK2636771	PI3K inhibitor	Phase 2	dmGWAS	GCST004988
140	PIK3CB	idelalisib	PI3K inhibitor	Launched	dmGWAS	GCST004988
141	PIK3CB	LY294002	DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor	Preclinical	dmGWAS	GCST004988
142	PIK3CB	PI-103	mTOR inhibitor|PI3K inhibitor	Preclinical	dmGWAS	GCST004988
143	PIK3CB	PIK-293	PI3K inhibitor	Preclinical	dmGWAS	GCST004988
144	PIK3CB	PIK-294	PI3K inhibitor	Preclinical	dmGWAS	GCST004988
145	PIK3CB	PIK-75	DNA protein kinase inhibitor|PI3K inhibitor	Preclinical	dmGWAS	GCST004988
146	PIK3CB	PP-121	protein tyrosine kinase inhibitor	Preclinical	dmGWAS	GCST004988
147	PIK3CB	SB-2343	mTOR inhibitor|PI3K inhibitor	Phase 1	dmGWAS	GCST004988
148	PIK3CB	TGX-221	PI3K inhibitor	Preclinical	dmGWAS	GCST004988
149	PIK3CB	TG100-115	PI3K inhibitor	Phase 1/Phase 2	dmGWAS	GCST004988
150	PIK3CB	ZSTK-474	PI3K inhibitor	Phase 1/Phase 2	dmGWAS	GCST004988
151	CYP11A1	aminoglutethimide	glucocorticoid receptor antagonist	Launched	dmGWAS	GCST004988
152	CYP11A1	mitotane	antineoplastic agent	Launched	dmGWAS	GCST004988
153	MTOR	AP1903		Phase 1/Phase 2	dmGWAS	GCST004988
154	MTOR	AZD2014	mTOR inhibitor	Phase 2	dmGWAS	GCST004988
155	MTOR	AZD8055	mTOR inhibitor	Phase 1	dmGWAS	GCST004988
156	MTOR	AZ20	ATR kinase inhibitor	Preclinical	dmGWAS	GCST004988
157	MTOR	beta-hydroxy-beta-methylbutyrate	protein synthesis stimulant	Launched	dmGWAS	GCST004988
158	MTOR	BGT226	PI3K inhibitor	Phase 1/Phase 2	dmGWAS	GCST004988
159	MTOR	CC-115	DNA protein kinase inhibitor|mTOR inhibitor	Phase 2	dmGWAS	GCST004988
160	MTOR	CC-223	mTOR inhibitor	Phase 2	dmGWAS	GCST004988
161	MTOR	chrysophanic-acid	EGFR inhibitor	Preclinical	dmGWAS	GCST004988
162	MTOR	CH5132799	PI3K inhibitor	Phase 1	dmGWAS	GCST004988
163	MTOR	compound-401	DNA dependent protein kinase inhibitor	Preclinical	dmGWAS	GCST004988
164	MTOR	deforolimus	mTOR inhibitor	Phase 3	dmGWAS	GCST004988
165	MTOR	everolimus	mTOR inhibitor	Launched	dmGWAS	GCST004988
166	MTOR	GDC-0980	mTOR inhibitor|PI3K inhibitor	Phase 2	dmGWAS	GCST004988
167	MTOR	GSK2126458	mTOR inhibitor|PI3K inhibitor	Phase 1	dmGWAS	GCST004988
168	MTOR	KU-0063794	mTOR inhibitor	Preclinical	dmGWAS	GCST004988
169	MTOR	LY294002	DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor	Preclinical	dmGWAS	GCST004988
170	MTOR	LY3023414	mTOR inhibitor|PI3K inhibitor	Phase 2	dmGWAS	GCST004988
171	MTOR	MLN0128	mTOR inhibitor	Phase 2	dmGWAS	GCST004988
172	MTOR	NVP-BEZ235	mTOR inhibitor|PI3K inhibitor	Phase 3	dmGWAS	GCST004988
173	MTOR	OSI-027	mTOR inhibitor	Phase 1	dmGWAS	GCST004988
174	MTOR	palomid-529	AKT inhibitor|mTOR inhibitor	Phase 1	dmGWAS	GCST004988
175	MTOR	PF-04691502	mTOR inhibitor|PI3K inhibitor	Phase 2	dmGWAS	GCST004988
176	MTOR	PF-05212384	mTOR inhibitor|PI3K inhibitor	Phase 2	dmGWAS	GCST004988
177	MTOR	PI-103	mTOR inhibitor|PI3K inhibitor	Preclinical	dmGWAS	GCST004988
178	MTOR	PKI-179	mTOR inhibitor|PI3K inhibitor	Phase 1	dmGWAS	GCST004988
179	MTOR	PP-121	protein tyrosine kinase inhibitor	Preclinical	dmGWAS	GCST004988
180	MTOR	PP242	mTOR inhibitor	Preclinical	dmGWAS	GCST004988
181	MTOR	SAR-245409	PI3K inhibitor	Phase 1/Phase 2	dmGWAS	GCST004988
182	MTOR	SB-2343	mTOR inhibitor|PI3K inhibitor	Phase 1	dmGWAS	GCST004988
183	MTOR	sirolimus	mTOR inhibitor	Launched	dmGWAS	GCST004988
184	MTOR	temsirolimus	mTOR inhibitor	Launched	dmGWAS	GCST004988
185	MTOR	torin-1	mTOR inhibitor	Preclinical	dmGWAS	GCST004988
186	MTOR	torin-2	mTOR inhibitor	Preclinical	dmGWAS	GCST004988
187	MTOR	VE-822	ATR kinase inhibitor	Phase 2	dmGWAS	GCST004988
188	MTOR	voxtalisib	mTOR inhibitor|PI3K inhibitor	Phase 2	dmGWAS	GCST004988
189	MTOR	WAY-600	mTOR inhibitor	Preclinical	dmGWAS	GCST004988
190	MTOR	WYE-125132	mTOR inhibitor	Preclinical	dmGWAS	GCST004988
191	MTOR	WYE-354	mTOR inhibitor	Preclinical	dmGWAS	GCST004988
192	MTOR	WYE-687	mTOR inhibitor	Preclinical	dmGWAS	GCST004988
193	MTOR	XL388	mTOR inhibitor	Preclinical	dmGWAS	GCST004988
194	PIK3CD	acalisib	PI3K inhibitor	Phase 1	dmGWAS	GCST004988
195	PIK3CD	alpelisib	PI3K inhibitor	Launched	dmGWAS	GCST004988
196	PIK3CD	AMG-319	PI3K inhibitor	Phase 2	dmGWAS	GCST004988
197	PIK3CD	AMG319	PI3K inhibitor	Phase 2	dmGWAS	GCST004988
198	PIK3CD	AZD6482	PI3K inhibitor	Phase 1	dmGWAS	GCST004988
199	PIK3CD	AZD8186	PI3K inhibitor	Phase 1	dmGWAS	GCST004988
200	PIK3CD	AZD8835	PI3K inhibitor	Phase 1	dmGWAS	GCST004988
201	PIK3CD	caffeine	adenosine receptor antagonist|phosphodiesterase inhibitor	Launched	dmGWAS	GCST004988
202	PIK3CD	CH5132799	PI3K inhibitor	Phase 1	dmGWAS	GCST004988
203	PIK3CD	copanlisib	PI3K inhibitor	Launched	dmGWAS	GCST004988
204	PIK3CD	duvelisib	PI3K inhibitor	Launched	dmGWAS	GCST004988
205	PIK3CD	ETP-45658	PI3K inhibitor	Preclinical	dmGWAS	GCST004988
206	PIK3CD	GDC-0941	PI3K inhibitor	Phase 2	dmGWAS	GCST004988
207	PIK3CD	GDC-0980	mTOR inhibitor|PI3K inhibitor	Phase 2	dmGWAS	GCST004988
208	PIK3CD	GSK2126458	mTOR inhibitor|PI3K inhibitor	Phase 1	dmGWAS	GCST004988
209	PIK3CD	idelalisib	PI3K inhibitor	Launched	dmGWAS	GCST004988
210	PIK3CD	LY294002	DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor	Preclinical	dmGWAS	GCST004988
211	PIK3CD	MLN0128	mTOR inhibitor	Phase 2	dmGWAS	GCST004988
212	PIK3CD	NVP-BEZ235	mTOR inhibitor|PI3K inhibitor	Phase 3	dmGWAS	GCST004988
213	PIK3CD	PI-103	mTOR inhibitor|PI3K inhibitor	Preclinical	dmGWAS	GCST004988
214	PIK3CD	PIK-293	PI3K inhibitor	Preclinical	dmGWAS	GCST004988
215	PIK3CD	PIK-294	PI3K inhibitor	Preclinical	dmGWAS	GCST004988
216	PIK3CD	PIK-75	DNA protein kinase inhibitor|PI3K inhibitor	Preclinical	dmGWAS	GCST004988
217	PIK3CD	PP-121	protein tyrosine kinase inhibitor	Preclinical	dmGWAS	GCST004988
218	PIK3CD	SB-2343	mTOR inhibitor|PI3K inhibitor	Phase 1	dmGWAS	GCST004988
219	PIK3CD	TGX-221	PI3K inhibitor	Preclinical	dmGWAS	GCST004988
220	PIK3CD	TG100-115	PI3K inhibitor	Phase 1/Phase 2	dmGWAS	GCST004988
221	PIK3CD	wortmannin	PI3K inhibitor	Preclinical	dmGWAS	GCST004988
222	PIK3CD	XL147	PI3K inhibitor	Phase 2	dmGWAS	GCST004988
223	PIK3CD	ZSTK-474	PI3K inhibitor	Phase 1/Phase 2	dmGWAS	GCST004988
224	RRM1	caracemide	ribonucleotide reductase inhibitor	Phase 2	dmGWAS	GCST004748
225	RRM1	cladribine	adenosine deaminase inhibitor|ribonucleotide reductase inhibitor	Launched	dmGWAS	GCST004748
226	RRM1	clofarabine	ribonucleotide reductase inhibitor	Launched	dmGWAS	GCST004748
227	RRM1	didox	ribonucleotide reductase inhibitor	Launched	dmGWAS	GCST004748
228	RRM1	enocitabine	DNA synthesis inhibitor	Launched	dmGWAS	GCST004748
229	RRM1	fludarabine	ribonucleotide reductase inhibitor	Launched	dmGWAS	GCST004748
230	RRM1	fludarabine-phosphate	ribonucleotide reductase inhibitor	Launched	dmGWAS	GCST004748
231	RRM1	gemcitabine	ribonucleotide reductase inhibitor	Launched	dmGWAS	GCST004748
232	RRM1	gemcitabine-elaidate	apoptosis inhibitor|DNA synthesis inhibitor	Phase 1	dmGWAS	GCST004748
233	RRM1	hydroxyurea	ribonucleotide reductase inhibitor	Launched	dmGWAS	GCST004748
234	RRM1	triapine	ribonucleotide reductase inhibitor	Phase 2	dmGWAS	GCST004748
235	TUBB	ABT-751	tubulin polymerization inhibitor	Phase 2	dmGWAS	GCST004748
236	TUBB	albendazole	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004748
237	TUBB	cabazitaxel	microtubule inhibitor	Launched	dmGWAS	GCST004748
238	TUBB	carbendazim	microtubule inhibitor|tubulin polymerization inhibitor	Launched	dmGWAS	GCST004748
239	TUBB	cevipabulin	microtubule stimulant|tubulin polymerization inhibitor	Phase 1	dmGWAS	GCST004748
240	TUBB	colchicine	microtubule inhibitor	Launched	dmGWAS	GCST004748
241	TUBB	CYT-997	tubulin polymerization inhibitor	Phase 2	dmGWAS	GCST004748
242	TUBB	D-64131	microtubule inhibitor	Preclinical	dmGWAS	GCST004748
243	TUBB	docetaxel	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004748
244	TUBB	dolastatin-10	tubulin polymerization inhibitor	Phase 2	dmGWAS	GCST004748
245	TUBB	epothilone-B	microtubule stabilizing agent|tubulin polymerization inhibitor	Phase 3	dmGWAS	GCST004748
246	TUBB	epothilone-D	microtubule stabilizing agent|tubulin polymerization inhibitor	Phase 2	dmGWAS	GCST004748
247	TUBB	fenbendazole	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004748
248	TUBB	flubendazole	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004748
249	TUBB	ixabepilone	microtubule stabilizing agent	Launched	dmGWAS	GCST004748
250	TUBB	mebendazole	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004748
251	TUBB	oxibendazole	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004748
252	TUBB	paclitaxel	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004748
253	TUBB	parbendazole	tubulin polymerization inhibitor	Preclinical	dmGWAS	GCST004748
254	TUBB	podophyllotoxin	microtubule inhibitor|tubulin polymerization inhibitor	Launched	dmGWAS	GCST004748
255	TUBB	verubulin	tubulin polymerization inhibitor	Phase 2	dmGWAS	GCST004748
256	TUBB	vinblastine	microtubule inhibitor|tubulin polymerization inhibitor	Launched	dmGWAS	GCST004748
257	TUBB	vincristine	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004748
258	TUBB	vindesine	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004748
259	TUBB	vinorelbine	tubulin polymerization inhibitor	Launched	dmGWAS	GCST004748
260	TUBB	2-methoxyestradiol	hypoxia inducible factor inhibitor	Phase 2	dmGWAS	GCST004748
261	PDGFRB	AC-710	PDGFR tyrosine kinase receptor inhibitor	Preclinical	dmGWAS	GCST90129505
262	PDGFRB	anlotinib	PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	Launched	dmGWAS	GCST90129505
263	PDGFRB	BMS-536924	IGF-1 inhibitor	Preclinical	dmGWAS	GCST90129505
264	PDGFRB	cediranib	KIT inhibitor|VEGFR inhibitor	Phase 3	dmGWAS	GCST90129505
265	PDGFRB	CP-673451	PDGFR tyrosine kinase receptor inhibitor	Preclinical	dmGWAS	GCST90129505
266	PDGFRB	crenolanib	PDGFR tyrosine kinase receptor inhibitor	Phase 3	dmGWAS	GCST90129505
267	PDGFRB	dasatinib	Bcr-Abl kinase inhibitor|ephrin inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor|tyrosine kinase inhibitor	Launched	dmGWAS	GCST90129505
268	PDGFRB	dovitinib	EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	Phase 3	dmGWAS	GCST90129505
269	PDGFRB	flumatinib	Bcr-Abl kinase inhibitor	Phase 3	dmGWAS	GCST90129505
270	PDGFRB	GTP-14564	FLT3 inhibitor|tyrosine kinase inhibitor	Preclinical	dmGWAS	GCST90129505
271	PDGFRB	imatinib	Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor	Launched	dmGWAS	GCST90129505
272	PDGFRB	KG-5	RAF inhibitor	Preclinical	dmGWAS	GCST90129505
273	PDGFRB	KI-20227	c-Fms inhibitor	Preclinical	dmGWAS	GCST90129505
274	PDGFRB	linifanib	PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	Phase 3	dmGWAS	GCST90129505
275	PDGFRB	lucitanib	FGFR inhibitor|VEGFR inhibitor	Phase 2	dmGWAS	GCST90129505
276	PDGFRB	masitinib	KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor	Launched	dmGWAS	GCST90129505
277	PDGFRB	MK-2461	FGFR inhibitor|VEGFR inhibitor	Phase 1/Phase 2	dmGWAS	GCST90129505
278	PDGFRB	nintedanib	FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	Launched	dmGWAS	GCST90129505
279	PDGFRB	ON123300	CDK inhibitor	Preclinical	dmGWAS	GCST90129505
280	PDGFRB	orantinib	FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	Phase 3	dmGWAS	GCST90129505
281	PDGFRB	pazopanib	KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	Launched	dmGWAS	GCST90129505
282	PDGFRB	PD-166285	SRC inhibitor	Preclinical	dmGWAS	GCST90129505
283	PDGFRB	PD-173074	FGFR inhibitor|VEGFR inhibitor	Preclinical	dmGWAS	GCST90129505
284	PDGFRB	quizartinib	FLT3 inhibitor	Phase 3	dmGWAS	GCST90129505
285	PDGFRB	regorafenib	FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor	Launched	dmGWAS	GCST90129505
286	PDGFRB	semaxanib	VEGFR inhibitor	Phase 3	dmGWAS	GCST90129505
287	PDGFRB	sorafenib	FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor	Launched	dmGWAS	GCST90129505
288	PDGFRB	sunitinib	FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor	Launched	dmGWAS	GCST90129505
289	PDGFRB	SU16f	PDGFR tyrosine kinase receptor inhibitor	Preclinical	dmGWAS	GCST90129505
290	PDGFRB	SU4312	PDGFR tyrosine kinase receptor inhibitor|tyrosine kinase inhibitor|VEGFR inhibitor	Preclinical	dmGWAS	GCST90129505
291	PDGFRB	tandutinib	FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor	Phase 2	dmGWAS	GCST90129505
292	PDGFRB	tivozanib	VEGFR inhibitor	Launched	dmGWAS	GCST90129505
293	PDGFRB	toceranib	protein tyrosine kinase inhibitor	Launched	dmGWAS	GCST90129505
294	PDGFRB	vatalanib	KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	Phase 3	dmGWAS	GCST90129505
295	TNF	amrinone	phosphodiesterase inhibitor	Launched	dmGWAS	GCST007692
296	TNF	andrographolide	tumor necrosis factor production inhibitor	Phase 2	dmGWAS	GCST007692
297	TNF	baicalein	lipoxygenase inhibitor	Preclinical	dmGWAS	GCST007692
298	TNF	bergenin	interleukin inhibitor	Preclinical	dmGWAS	GCST007692
299	TNF	CPI-1189	tumor necrosis factor release inhibitor	Phase 2	dmGWAS	GCST007692
300	TNF	ephedrine-(racemic)	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
301	TNF	epinephrine	adrenergic receptor agonist|carbonic anhydrase activator|neurotransmitter	Launched	dmGWAS	GCST007692
302	TNF	glycitein	tumor necrosis factor release inhibitor	Phase 3	dmGWAS	GCST007692
303	TNF	hypoestoxide	IKK inhibitor	Phase 1	dmGWAS	GCST007692
304	TNF	JTE-607	cytokine production inhibitor	Phase 2	dmGWAS	GCST007692
305	TNF	lenalidomide	anticancer agent	Launched	dmGWAS	GCST007692
306	TNF	ligustilide	tumor necrosis factor production inhibitor	Preclinical	dmGWAS	GCST007692
307	TNF	pentoxifylline	phosphodiesterase inhibitor	Launched	dmGWAS	GCST007692
308	TNF	pirfenidone	TGF beta receptor inhibitor	Launched	dmGWAS	GCST007692
309	TNF	pranlukast	leukotriene receptor antagonist	Launched	dmGWAS	GCST007692
310	TNF	SB-203580	p38 MAPK inhibitor	Preclinical	dmGWAS	GCST007692
311	TNF	talmapimod	p38 MAPK inhibitor	Phase 2	dmGWAS	GCST007692
312	TNF	tanshinone-IIA	anti-inflammatory agent|interleukin inhibitor	Phase 2/Phase 3	dmGWAS	GCST007692
313	TNF	thalidomide	tumor necrosis factor production inhibitor	Launched	dmGWAS	GCST007692
314	TNF	trofinetide	cytokine production inhibitor	Phase 2	dmGWAS	GCST007692
315	TNF	VX-702	p38 MAPK inhibitor	Phase 2	dmGWAS	GCST007692
316	IL5	pranlukast	leukotriene receptor antagonist	Launched	dmGWAS	GCST007692
317	CHRM3	A-987306	histamine receptor antagonist	Preclinical	dmGWAS	GCST007692
318	CHRM3	aceclidine	acetylcholine receptor agonist	Launched	dmGWAS	GCST007692
319	CHRM3	acetylcholine	acetylcholine receptor agonist	Launched	dmGWAS	GCST007692
320	CHRM3	aclidinium	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
321	CHRM3	alcuronium	muscle relaxant	Launched	dmGWAS	GCST007692
322	CHRM3	amitriptyline	norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotoninâ€“norepinephrine reuptake inhibitor (SNRI)	Launched	dmGWAS	GCST007692
323	CHRM3	amoxapine	norepinephrine reputake inhibitor	Launched	dmGWAS	GCST007692
324	CHRM3	arecaidine-propargyl-ester	acetylcholine receptor agonist	Preclinical	dmGWAS	GCST007692
325	CHRM3	arecoline	acetylcholine receptor agonist	Phase 1	dmGWAS	GCST007692
326	CHRM3	aripiprazole	serotonin receptor agonist|serotonin receptor antagonist	Launched	dmGWAS	GCST007692
327	CHRM3	atropine	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
328	CHRM3	atropine-oxide	acetylcholine receptor antagonist	Preclinical	dmGWAS	GCST007692
329	CHRM3	bethanechol	acetylcholine receptor agonist	Launched	dmGWAS	GCST007692
330	CHRM3	biperiden	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
331	CHRM3	brucine	glycine receptor antagonist	Preclinical	dmGWAS	GCST007692
332	CHRM3	carbachol	cholinergic receptor agonist	Launched	dmGWAS	GCST007692
333	CHRM3	cevimeline	acetylcholine receptor agonist	Launched	dmGWAS	GCST007692
334	CHRM3	chlorpromazine	dopamine receptor antagonist	Launched	dmGWAS	GCST007692
335	CHRM3	chlorprothixene	dopamine receptor antagonist	Launched	dmGWAS	GCST007692
336	CHRM3	clidinium	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
337	CHRM3	clozapine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	dmGWAS	GCST007692
338	CHRM3	curcumin	cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor	Launched	dmGWAS	GCST007692
339	CHRM3	cyproheptadine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
340	CHRM3	darifenacin	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
341	CHRM3	DAU-5884	acetylcholine receptor antagonist	Preclinical	dmGWAS	GCST007692
342	CHRM3	desipramine	tricyclic antidepressant	Launched	dmGWAS	GCST007692
343	CHRM3	dicycloverine	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
344	CHRM3	diphemanil	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
345	CHRM3	diphenidol	acetylcholine receptor agonist	Launched	dmGWAS	GCST007692
346	CHRM3	disopyramide	sodium channel blocker	Launched	dmGWAS	GCST007692
347	CHRM3	dosulepin	norepinephrine reuptake inhibitor|serotoninâ€“norepinephrine reuptake inhibitor (SNRI)|tricyclic antidepressant	Launched	dmGWAS	GCST007692
348	CHRM3	fesoterodine	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
349	CHRM3	glycopyrrolate	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
350	CHRM3	hyoscyamine	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
351	CHRM3	imidafenacin	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
352	CHRM3	imipramine	norepinephrine reputake inhibitor|serotonin reuptake inhibitor	Launched	dmGWAS	GCST007692
353	CHRM3	ipratropium	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
354	CHRM3	isopropamide-iodide	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
355	CHRM3	itopride	dopamine receptor antagonist	Launched	dmGWAS	GCST007692
356	CHRM3	levomepromazine	dopamine receptor antagonist	Launched	dmGWAS	GCST007692
357	CHRM3	loxapine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	dmGWAS	GCST007692
358	CHRM3	methscopolamine	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
359	CHRM3	nortriptyline	tricyclic antidepressant	Launched	dmGWAS	GCST007692
360	CHRM3	olanzapine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	dmGWAS	GCST007692
361	CHRM3	otenzepad	acetylcholine receptor antagonist	Phase 3	dmGWAS	GCST007692
362	CHRM3	oxotremorine-M	acetylcholine receptor agonist	Preclinical	dmGWAS	GCST007692
363	CHRM3	oxotremorine-sesquifumarate	cholinergic receptor agonist	Preclinical	dmGWAS	GCST007692
364	CHRM3	oxybutynin	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
365	CHRM3	oxyphenonium	cholinergic receptor antagonist	Launched	dmGWAS	GCST007692
366	CHRM3	pancuronium	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
367	CHRM3	paroxetine	selective serotonin reuptake inhibitor (SSRI)	Launched	dmGWAS	GCST007692
368	CHRM3	pilocarpine	acetylcholine receptor agonist	Launched	dmGWAS	GCST007692
369	CHRM3	pipecuronium	neuromuscular blocker	Launched	dmGWAS	GCST007692
370	CHRM3	pirenzepine	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
371	CHRM3	promazine	dopamine receptor antagonist	Launched	dmGWAS	GCST007692
372	CHRM3	propantheline	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
373	CHRM3	quetiapine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	dmGWAS	GCST007692
374	CHRM3	scopolamine	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
375	CHRM3	scopolamine-N-oxide	acetylcholine receptor antagonist	Preclinical	dmGWAS	GCST007692
376	CHRM3	solifenacin-succinate	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
377	CHRM3	strychnine	acetylcholine receptor antagonist	Preclinical	dmGWAS	GCST007692
378	CHRM3	succinylcholine-chloride		Launched	dmGWAS	GCST007692
379	CHRM3	tarafenacin	acetylcholine receptor antagonist	Phase 2	dmGWAS	GCST007692
380	CHRM3	tiotropium	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
381	CHRM3	tolterodine	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
382	CHRM3	trepibutone	cholinergic receptor antagonist	Launched	dmGWAS	GCST007692
383	CHRM3	tropicamide	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
384	CHRM3	umeclidinium	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
385	CHRM3	vinburnine	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
386	CHRM3	vincamine	adrenergic receptor antagonist	Withdrawn	dmGWAS	GCST007692
387	CHRM3	xanomeline	acetylcholine receptor agonist	Phase 3	dmGWAS	GCST007692
388	CHRM3	zamifenacin	acetylcholine receptor antagonist	Phase 3	dmGWAS	GCST007692
389	CHRM3	ziprasidone	dopamine receptor antagonist|serotonin receptor antagonist	Launched	dmGWAS	GCST007692
390	CHRM3	4-DAMP	cholinergic receptor antagonist	Preclinical	dmGWAS	GCST007692
391	CHRM3	5-hydroxymethyl-tolterodine	acetylcholine receptor antagonist	Phase 1	dmGWAS	GCST007692
392	CHRM3	5-methylfurmethiodide	acetylcholine receptor agonist	Preclinical	dmGWAS	GCST007692
393	HRH1	ABT-239	histamine receptor antagonist	Phase 1	dmGWAS	GCST007692
394	HRH1	acrivastine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
395	HRH1	alcaftadine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
396	HRH1	alimemazine	histamine receptor agonist|histamine receptor antagonist	Launched	dmGWAS	GCST007692
397	HRH1	amitriptyline	norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotoninâ€“norepinephrine reuptake inhibitor (SNRI)	Launched	dmGWAS	GCST007692
398	HRH1	amoxapine	norepinephrine reputake inhibitor	Launched	dmGWAS	GCST007692
399	HRH1	antazoline	antihistamine	Launched	dmGWAS	GCST007692
400	HRH1	aripiprazole	serotonin receptor agonist|serotonin receptor antagonist	Launched	dmGWAS	GCST007692
401	HRH1	asenapine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	dmGWAS	GCST007692
402	HRH1	astemizole	histamine receptor antagonist	Withdrawn	dmGWAS	GCST007692
403	HRH1	azacyclonol	histamine receptor antagonist	Preclinical	dmGWAS	GCST007692
404	HRH1	azatadine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
405	HRH1	azelastine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
406	HRH1	benztropine-mesylate	acetylcholine receptor antagonist	Launched	dmGWAS	GCST007692
407	HRH1	bepotastine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
408	HRH1	betahistine	histamine receptor agonist|histamine receptor antagonist	Launched	dmGWAS	GCST007692
409	HRH1	bilastine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
410	HRH1	brompheniramine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
411	HRH1	buclizine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
412	HRH1	carbinoxamine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
413	HRH1	carebastine	histamine receptor antagonist	Phase 1	dmGWAS	GCST007692
414	HRH1	cetirizine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
415	HRH1	chloropyramine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
416	HRH1	chlorpromazine	dopamine receptor antagonist	Launched	dmGWAS	GCST007692
417	HRH1	chlorprothixene	dopamine receptor antagonist	Launched	dmGWAS	GCST007692
418	HRH1	citalopram	selective serotonin reuptake inhibitor (SSRI)	Launched	dmGWAS	GCST007692
419	HRH1	clemastine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
420	HRH1	clobenpropit	histamine receptor antagonist	Preclinical	dmGWAS	GCST007692
421	HRH1	clofedanol	histamine receptor antagonist	Launched	dmGWAS	GCST007692
422	HRH1	clorotepine	adrenergic receptor antagonist|dopamine receptor antagonist	Launched	dmGWAS	GCST007692
423	HRH1	clozapine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	dmGWAS	GCST007692
424	HRH1	cyclizine	histamine receptor modulator	Launched	dmGWAS	GCST007692
425	HRH1	cyproheptadine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
426	HRH1	deptropine	histamine receptor antagonist	Preclinical	dmGWAS	GCST007692
427	HRH1	desipramine	tricyclic antidepressant	Launched	dmGWAS	GCST007692
428	HRH1	desloratadine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
429	HRH1	dimenhydrinate	histamine receptor antagonist	Launched	dmGWAS	GCST007692
430	HRH1	dimethindene-(S)-(+)	acetylcholine receptor antagonist	Preclinical	dmGWAS	GCST007692
431	HRH1	dimetindene	cholinergic receptor antagonist|histamine receptor antagonist	Launched	dmGWAS	GCST007692
432	HRH1	diphenhydramine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
433	HRH1	diphenylpyraline	dopamine reuptake inhibitor	Launched	dmGWAS	GCST007692
434	HRH1	dosulepin	norepinephrine reuptake inhibitor|serotoninâ€“norepinephrine reuptake inhibitor (SNRI)|tricyclic antidepressant	Launched	dmGWAS	GCST007692
435	HRH1	doxepin	histamine receptor antagonist	Launched	dmGWAS	GCST007692
436	HRH1	doxylamine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
437	HRH1	DPPE	histamine receptor antagonist	Phase 3	dmGWAS	GCST007692
438	HRH1	ebastine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
439	HRH1	emedastine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
440	HRH1	epinastine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
441	HRH1	fexofenadine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
442	HRH1	flunarizine	calcium channel blocker	Launched	dmGWAS	GCST007692
443	HRH1	fluphenazine	dopamine receptor antagonist	Launched	dmGWAS	GCST007692
444	HRH1	fluspirilene	dopamine receptor antagonist	Launched	dmGWAS	GCST007692
445	HRH1	haloperidol	dopamine receptor antagonist	Launched	dmGWAS	GCST007692
446	HRH1	histamine	histamine receptor agonist	Launched	dmGWAS	GCST007692
447	HRH1	homochlorcyclizine	antihistamine	Launched	dmGWAS	GCST007692
448	HRH1	hydroxyzine	antihistamine	Launched	dmGWAS	GCST007692
449	HRH1	iloperidone	dopamine receptor antagonist|serotonin receptor antagonist	Launched	dmGWAS	GCST007692
450	HRH1	imipramine	norepinephrine reputake inhibitor|serotonin reuptake inhibitor	Launched	dmGWAS	GCST007692
451	HRH1	ketotifen	histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor	Launched	dmGWAS	GCST007692
452	HRH1	latrepirdine	glutamate receptor antagonist	Phase 3	dmGWAS	GCST007692
453	HRH1	levocabastine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
454	HRH1	levocetirizine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
455	HRH1	levomepromazine	dopamine receptor antagonist	Launched	dmGWAS	GCST007692
456	HRH1	levomequitazine	histamine receptor antagonist	Phase 2	dmGWAS	GCST007692
457	HRH1	loratadine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
458	HRH1	loxapine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	dmGWAS	GCST007692
459	HRH1	mepyramine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
460	HRH1	methapyrilene	histamine receptor antagonist	Withdrawn	dmGWAS	GCST007692
461	HRH1	mianserin	serotonin receptor antagonist	Launched	dmGWAS	GCST007692
462	HRH1	mizolastine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
463	HRH1	molindone	dopamine receptor antagonist	Launched	dmGWAS	GCST007692
464	HRH1	nortriptyline	tricyclic antidepressant	Launched	dmGWAS	GCST007692
465	HRH1	olanzapine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	dmGWAS	GCST007692
466	HRH1	olopatadine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
467	HRH1	oxatomide	histamine receptor antagonist	Launched	dmGWAS	GCST007692
468	HRH1	pemirolast	mediator release inhibitor	Launched	dmGWAS	GCST007692
469	HRH1	perphenazine	dopamine receptor antagonist	Launched	dmGWAS	GCST007692
470	HRH1	phenindamine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
471	HRH1	pheniramine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
472	HRH1	pimozide	dopamine receptor antagonist	Launched	dmGWAS	GCST007692
473	HRH1	pipamperone	dopamine receptor antagonist	Launched	dmGWAS	GCST007692
474	HRH1	promazine	dopamine receptor antagonist	Launched	dmGWAS	GCST007692
475	HRH1	promethazine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
476	HRH1	quetiapine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	dmGWAS	GCST007692
477	HRH1	risperidone	dopamine receptor antagonist|serotonin receptor antagonist	Launched	dmGWAS	GCST007692
478	HRH1	rupatadine	histamine receptor antagonist|platelet activating factor receptor antagonist	Launched	dmGWAS	GCST007692
479	HRH1	sertindole	dopamine receptor antagonist|serotonin receptor antagonist	Withdrawn	dmGWAS	GCST007692
480	HRH1	setiptiline	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
481	HRH1	terfenadine	histamine receptor antagonist	Withdrawn	dmGWAS	GCST007692
482	HRH1	thioridazine	dopamine receptor antagonist	Withdrawn	dmGWAS	GCST007692
483	HRH1	thiothixene	dopamine receptor antagonist	Launched	dmGWAS	GCST007692
484	HRH1	tolazoline	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
485	HRH1	tranilast	angiogenesis inhibitor	Launched	dmGWAS	GCST007692
486	HRH1	trazodone	adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor	Launched	dmGWAS	GCST007692
487	HRH1	trifluoperazine	dopamine receptor antagonist	Launched	dmGWAS	GCST007692
488	HRH1	tripelennamine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
489	HRH1	triprolidine	histamine receptor antagonist	Launched	dmGWAS	GCST007692
490	HRH1	vilazodone	serotonin reuptake inhibitor	Launched	dmGWAS	GCST007692
491	HRH1	ziprasidone	dopamine receptor antagonist|serotonin receptor antagonist	Launched	dmGWAS	GCST007692
492	HRH1	zotepine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	dmGWAS	GCST007692
493	HRH1	zuclopenthixol	dopamine receptor antagonist	Launched	dmGWAS	GCST007692
494	HRH1	2-pyridylethylamine	histamine receptor agonist	Preclinical	dmGWAS	GCST007692
495	ADRB2	albuterol	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
496	ADRB2	alprenolol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
497	ADRB2	amezinium	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
498	ADRB2	amitriptyline	norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotoninâ€“norepinephrine reuptake inhibitor (SNRI)	Launched	dmGWAS	GCST007692
499	ADRB2	atenolol-(+/-)	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
500	ADRB2	bambuterol	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
501	ADRB2	betaxolol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
502	ADRB2	BRL-37344	adrenergic receptor agonist	Phase 2	dmGWAS	GCST007692
503	ADRB2	broxaterol	adrenergic receptor agonist	Phase 3	dmGWAS	GCST007692
504	ADRB2	buphenine	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
505	ADRB2	bupranolol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
506	ADRB2	cabergoline	dopamine receptor agonist	Launched	dmGWAS	GCST007692
507	ADRB2	carazolol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
508	ADRB2	carmoterol	adrenergic receptor agonist	Phase 2	dmGWAS	GCST007692
509	ADRB2	carteolol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
510	ADRB2	carvedilol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
511	ADRB2	celiprolol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
512	ADRB2	CGP-12177	adrenergic receptor agonist	Phase 1	dmGWAS	GCST007692
513	ADRB2	cimaterol	adrenergic receptor agonist	Preclinical	dmGWAS	GCST007692
514	ADRB2	clenbuterol	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
515	ADRB2	cloranolol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
516	ADRB2	clorprenaline	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
517	ADRB2	desipramine	tricyclic antidepressant	Launched	dmGWAS	GCST007692
518	ADRB2	dobutamine	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
519	ADRB2	DPI-201106	sodium channel activator	Phase 2	dmGWAS	GCST007692
520	ADRB2	droxidopa	norepinephrine precursor	Launched	dmGWAS	GCST007692
521	ADRB2	ephedrine	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
522	ADRB2	ephedrine-(racemic)	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
523	ADRB2	epinephrine	adrenergic receptor agonist|carbonic anhydrase activator|neurotransmitter	Launched	dmGWAS	GCST007692
524	ADRB2	fenoterol	adrenergic receptor agonist	Withdrawn	dmGWAS	GCST007692
525	ADRB2	formoterol	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
526	ADRB2	hexoprenaline	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
527	ADRB2	higenamine	adrenergic receptor agonist	Phase 1	dmGWAS	GCST007692
528	ADRB2	ICI-118,551	adrenergic receptor antagonist	Phase 2	dmGWAS	GCST007692
529	ADRB2	ICI-89406	adrenergic receptor antagonist	Phase 1	dmGWAS	GCST007692
530	ADRB2	indacaterol	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
531	ADRB2	isoprenaline	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
532	ADRB2	isoxsuprine	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
533	ADRB2	L-755507	adrenergic receptor agonist	Preclinical	dmGWAS	GCST007692
534	ADRB2	labetalol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
535	ADRB2	levalbuterol	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
536	ADRB2	levobetaxolol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
537	ADRB2	levobunolol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
538	ADRB2	mabuterol	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
539	ADRB2	mephentermine	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
540	ADRB2	metaproterenol	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
541	ADRB2	metoprolol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
542	ADRB2	mirabegron	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
543	ADRB2	nadolol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
544	ADRB2	nifenalol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
545	ADRB2	norepinephrine	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
546	ADRB2	nortriptyline	tricyclic antidepressant	Launched	dmGWAS	GCST007692
547	ADRB2	olanzapine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	dmGWAS	GCST007692
548	ADRB2	penbutolol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
549	ADRB2	pindolol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
550	ADRB2	procaterol	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
551	ADRB2	propafenone	antiarrhythmic	Launched	dmGWAS	GCST007692
552	ADRB2	propranolol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
553	ADRB2	propranolol-(R)	adrenergic receptor antagonist	Preclinical	dmGWAS	GCST007692
554	ADRB2	RU-42173	adrenergic receptor agonist	Phase 2	dmGWAS	GCST007692
555	ADRB2	salmeterol	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
556	ADRB2	sotalol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
557	ADRB2	SR-59230A	adrenergic receptor antagonist	Preclinical	dmGWAS	GCST007692
558	ADRB2	terbutaline	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
559	ADRB2	timolol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
560	ADRB2	tiprenolol	adrenergic receptor antagonist	Phase 2	dmGWAS	GCST007692
561	ADRB2	tolamolol	adrenergic receptor antagonist	Phase 3	dmGWAS	GCST007692
562	ADRB2	trimethoquinol	adrenergic receptor antagonist	Launched	dmGWAS	GCST007692
563	ADRB2	tulobuterol	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
564	ADRB2	vilanterol	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
565	ADRB2	zilpaterol	adrenergic receptor agonist	Launched	dmGWAS	GCST007692
566	S100A12	amlexanox	histamine receptor modulator	Launched	dmGWAS	GCST009841
567	S100A12	olopatadine	histamine receptor antagonist	Launched	dmGWAS	GCST009841
568	IL6	andrographolide	tumor necrosis factor production inhibitor	Phase 2	dmGWAS	GCST009841
569	IL6	ibudilast	leukotriene receptor antagonist|phosphodiesterase inhibitor	Launched	dmGWAS	GCST009841
570	IL6	JTE-607	cytokine production inhibitor	Phase 2	dmGWAS	GCST009841
571	IL6	trofinetide	cytokine production inhibitor	Phase 2	dmGWAS	GCST009841
572	IL6	VX-702	p38 MAPK inhibitor	Phase 2	dmGWAS	GCST009841
573	ADORA1	A-987306	histamine receptor antagonist	Preclinical	dmGWAS	GCST009841
574	ADORA1	acefylline	adenosine receptor agonist	Launched	dmGWAS	GCST009841
575	ADORA1	adenosine	adenosine receptor agonist	Launched	dmGWAS	GCST009841
576	ADORA1	aminophylline	adenosine receptor antagonist	Launched	dmGWAS	GCST009841
577	ADORA1	BAY-60-6583	adenosine receptor agonist	Preclinical	dmGWAS	GCST009841
578	ADORA1	caffeine	adenosine receptor antagonist|phosphodiesterase inhibitor	Launched	dmGWAS	GCST009841
579	ADORA1	capadenoson	adenosine receptor agonist	Phase 2	dmGWAS	GCST009841
580	ADORA1	CF102	adenosine receptor agonist	Phase 2	dmGWAS	GCST009841
581	ADORA1	CGH2466	adenosine receptor antagonist	Preclinical	dmGWAS	GCST009841
582	ADORA1	CGS-15943	adenosine receptor antagonist	Preclinical	dmGWAS	GCST009841
583	ADORA1	CGS-21680	adenosine receptor agonist	Preclinical	dmGWAS	GCST009841
584	ADORA1	cyproterone-acetate	androgen receptor antagonist	Launched	dmGWAS	GCST009841
585	ADORA1	doxofylline	adenosine receptor antagonist	Launched	dmGWAS	GCST009841
586	ADORA1	DPCPX	adenosine receptor antagonist	Phase 1	dmGWAS	GCST009841
587	ADORA1	enprofylline	phosphodiesterase inhibitor	Phase 3	dmGWAS	GCST009841
588	ADORA1	etofylline	adenosine receptor antagonist	Launched	dmGWAS	GCST009841
589	ADORA1	gabapentin	calcium channel blocker	Launched	dmGWAS	GCST009841
590	ADORA1	GR-79236	adenosine receptor agonist	Phase 1	dmGWAS	GCST009841
591	ADORA1	GS-6201	adenosine receptor antagonist	Phase 1	dmGWAS	GCST009841
592	ADORA1	HEMADO	adenosine receptor agonist	Preclinical	dmGWAS	GCST009841
593	ADORA1	IB-MECA	adenosine receptor agonist	Phase 3	dmGWAS	GCST009841
594	ADORA1	IBMX	phosphodiesterase inhibitor	Preclinical	dmGWAS	GCST009841
595	ADORA1	istradefylline	adenosine receptor antagonist	Launched	dmGWAS	GCST009841
596	ADORA1	KW-3902	adenosine receptor antagonist	Phase 3	dmGWAS	GCST009841
597	ADORA1	MRS-3777	adenosine receptor antagonist	Preclinical	dmGWAS	GCST009841
598	ADORA1	NECA	adenosine receptor agonist	Launched	dmGWAS	GCST009841
599	ADORA1	N6-cyclopentyladenosine	adenosine receptor agonist	Preclinical	dmGWAS	GCST009841
600	ADORA1	PD-81723	adenosine receptor agonist	Preclinical	dmGWAS	GCST009841
601	ADORA1	pentoxifylline	phosphodiesterase inhibitor	Launched	dmGWAS	GCST009841
602	ADORA1	preladenant	adenosine receptor antagonist	Phase 3	dmGWAS	GCST009841
603	ADORA1	PSB-11	adenosine receptor antagonist	Preclinical	dmGWAS	GCST009841
604	ADORA1	PSB-1115	adenosine receptor antagonist	Preclinical	dmGWAS	GCST009841
605	ADORA1	PSB-36	adenosine receptor antagonist	Preclinical	dmGWAS	GCST009841
606	ADORA1	PSB-603	adenosine receptor antagonist	Preclinical	dmGWAS	GCST009841
607	ADORA1	regadenoson	adenosine receptor agonist	Launched	dmGWAS	GCST009841
608	ADORA1	SCH-58261	adenosine receptor antagonist	Preclinical	dmGWAS	GCST009841
609	ADORA1	SDZ-WAG-994	adenosine receptor agonist	Phase 2	dmGWAS	GCST009841
610	ADORA1	SLV-320	adenosine receptor antagonist	Phase 2	dmGWAS	GCST009841
611	ADORA1	tecadenoson	adenosine receptor agonist	Phase 2	dmGWAS	GCST009841
612	ADORA1	theobromine	phosphodiesterase inhibitor	Launched	dmGWAS	GCST009841
613	ADORA1	vipadenant	adenosine receptor antagonist	Phase 1	dmGWAS	GCST009841
614	ADORA1	ZM-241385	adenosine receptor antagonist	Preclinical	dmGWAS	GCST009841
615	ADORA1	2'-MeCCPA	adenosine receptor agonist	Preclinical	dmGWAS	GCST009841
616	ADORA1	2-chloro-N6-cyclopentyladenosine	adenosine receptor agonist	Preclinical	dmGWAS	GCST009841
617	ADORA1	2-chloroadenosine	adenosine receptor agonist	Preclinical	dmGWAS	GCST009841
618	ADORA1	5'-chloro-5'-deoxy-ENBA-(+/-)	adenosine receptor agonist	Preclinical	dmGWAS	GCST009841
619	RRM2	cladribine	adenosine deaminase inhibitor|ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST004988
620	RRM2	clofarabine	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST004988
621	RRM2	fludarabine	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST004988
622	RRM2	fludarabine-phosphate	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST004988
623	RRM2	gemcitabine	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST004988
624	RRM2	hydroxyurea	ribonucleotide reductase inhibitor	Launched	RMM-GWAS	GCST004988
625	RRM2	triapine	ribonucleotide reductase inhibitor	Phase 2	RMM-GWAS	GCST004988
626	ESR1	afimoxifene	estrogen receptor antagonist	Phase 2	RMM-GWAS	GCST004988
627	ESR1	allylestrenol	steroidal progestin	Launched	RMM-GWAS	GCST004988
628	ESR1	AZD9496	estrogen receptor agonist	Phase 1	RMM-GWAS	GCST004988
629	ESR1	bazedoxifene	selective estrogen receptor modulator (SERM)	Launched	RMM-GWAS	GCST004988
630	ESR1	benfluralin		Phase 3	RMM-GWAS	GCST004988
631	ESR1	bisphenol-A	synthetic estrogen	Phase 1	RMM-GWAS	GCST004988
632	ESR1	bithionol	autotaxin inhibitor	Withdrawn	RMM-GWAS	GCST004988
633	ESR1	chlorotrianisene	estrogenic hormone	Launched	RMM-GWAS	GCST004988
634	ESR1	clomifene	estrogen receptor antagonist	Launched	RMM-GWAS	GCST004988
635	ESR1	danazol	estrogen receptor antagonist|progesterone receptor agonist	Launched	RMM-GWAS	GCST004988
636	ESR1	dehydroepiandrosterone	protein synthesis stimulant	Launched	RMM-GWAS	GCST004988
637	ESR1	dehydroepiandrosterone-sulfate	androgen receptor agonist|estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
638	ESR1	desogestrel	progesterone receptor agonist	Launched	RMM-GWAS	GCST004988
639	ESR1	dienestrol	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
640	ESR1	diethylstilbestrol	estrogen receptor agonist	Withdrawn	RMM-GWAS	GCST004988
641	ESR1	droloxifene	selective estrogen receptor modulator (SERM)	Phase 3	RMM-GWAS	GCST004988
642	ESR1	endoxifen	estrogen receptor antagonist	Phase 2	RMM-GWAS	GCST004988
643	ESR1	equol	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
644	ESR1	erteberel	estrogen receptor agonist	Phase 2	RMM-GWAS	GCST004988
645	ESR1	estetrol	selective estrogen receptor modulator (SERM)	Phase 3	RMM-GWAS	GCST004988
646	ESR1	estradiol	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
647	ESR1	estradiol-acetate	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
648	ESR1	estradiol-benzoate	contraceptive agent	Preclinical	RMM-GWAS	GCST004988
649	ESR1	estradiol-cypionate	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
650	ESR1	estradiol-valerate	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
651	ESR1	estramustine	DNA alkylating agent	Launched	RMM-GWAS	GCST004988
652	ESR1	estramustine-phosphate	DNA synthesis inhibitor|microtubule inhibitor	Launched	RMM-GWAS	GCST004988
653	ESR1	estriol	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
654	ESR1	estrone	estrogen receptor agonist|estrogenic hormone	Launched	RMM-GWAS	GCST004988
655	ESR1	estropipate	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
656	ESR1	ethinyl-estradiol	estrogen receptor agonist|estrogenic hormone	Launched	RMM-GWAS	GCST004988
657	ESR1	ethynodiol-diacetate		Launched	RMM-GWAS	GCST004988
658	ESR1	etonogestrel	progesterone receptor agonist	Launched	RMM-GWAS	GCST004988
659	ESR1	fosfestrol	synthetic estrogen	Launched	RMM-GWAS	GCST004988
660	ESR1	fulvestrant	estrogen receptor antagonist	Launched	RMM-GWAS	GCST004988
661	ESR1	GDC-0810	selective estrogen receptor destabilizer	Phase 2	RMM-GWAS	GCST004988
662	ESR1	genistein	tyrosine kinase inhibitor	Phase 2/Phase 3	RMM-GWAS	GCST004988
663	ESR1	gestrinone	progesterone receptor antagonist	Launched	RMM-GWAS	GCST004988
664	ESR1	hexestrol	synthetic estrogen	Launched	RMM-GWAS	GCST004988
665	ESR1	lasofoxifene	selective estrogen receptor modulator (SERM)	Launched	RMM-GWAS	GCST004988
666	ESR1	medroxyprogesterone-acetate	progesterone receptor agonist	Launched	RMM-GWAS	GCST004988
667	ESR1	melatonin	melatonin receptor agonist|nitric oxide synthase inhibitor	Launched	RMM-GWAS	GCST004988
668	ESR1	mestranol	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
669	ESR1	mitotane	antineoplastic agent	Launched	RMM-GWAS	GCST004988
670	ESR1	naloxone	opioid receptor antagonist	Launched	RMM-GWAS	GCST004988
671	ESR1	norgestimate	progesterone receptor agonist	Launched	RMM-GWAS	GCST004988
672	ESR1	norgestrel	progesterone receptor agonist	Launched	RMM-GWAS	GCST004988
673	ESR1	ospemifene	selective estrogen receptor modulator (SERM)	Launched	RMM-GWAS	GCST004988
674	ESR1	PPT	estrogen receptor agonist	Preclinical	RMM-GWAS	GCST004988
675	ESR1	progesterone	progesterone receptor agonist	Launched	RMM-GWAS	GCST004988
676	ESR1	promestriene	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
677	ESR1	quinestrol	estrogen receptor agonist	Launched	RMM-GWAS	GCST004988
678	ESR1	raloxifene	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	RMM-GWAS	GCST004988
679	ESR1	SNG-1153	selective estrogen receptor modulator (SERM)	Preclinical	RMM-GWAS	GCST004988
680	ESR1	tamoxifen	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	RMM-GWAS	GCST004988
681	ESR1	tibolone	androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist	Launched	RMM-GWAS	GCST004988
682	ESR1	toremifene	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	RMM-GWAS	GCST004988
683	ESR1	Y-134	estrogen receptor antagonist	Preclinical	RMM-GWAS	GCST004988
684	ESR1	ZK-164015	estrogen receptor antagonist	Preclinical	RMM-GWAS	GCST004988
685	ESR1	17-hydroxyprogesterone-caproate	progesterone receptor agonist	Launched	RMM-GWAS	GCST004988
686	CDK6	abemaciclib	CDK inhibitor	Launched	RMM-GWAS	GCST004988
687	CDK6	alvocidib	CDK inhibitor	Phase 2	RMM-GWAS	GCST004988
688	CDK6	AMG-925	CDK inhibitor|FLT3 inhibitor	Phase 1	RMM-GWAS	GCST004988
689	CDK6	apigenin	casein kinase inhibitor|cell proliferation inhibitor	Preclinical	RMM-GWAS	GCST004988
690	CDK6	AT-7519	CDK inhibitor	Phase 2	RMM-GWAS	GCST004988
691	CDK6	chrysin	breast cancer resistance protein inhibitor	Phase 1	RMM-GWAS	GCST004988
692	CDK6	fisetin	Aurora kinase inhibitor	Preclinical	RMM-GWAS	GCST004988
693	CDK6	palbociclib	CDK inhibitor	Launched	RMM-GWAS	GCST004988
694	CDK6	RGB-286638	CDK inhibitor	Phase 1	RMM-GWAS	GCST004988
695	CDK6	ribociclib	CDK inhibitor	Launched	RMM-GWAS	GCST004988
696	EGFR	AEE788	EGFR inhibitor|VEGFR inhibitor	Phase 1/Phase 2	RMM-GWAS	GCST004988
697	EGFR	afatinib	EGFR inhibitor	Launched	RMM-GWAS	GCST004988
698	EGFR	AG-490	EGFR inhibitor|JAK inhibitor	Preclinical	RMM-GWAS	GCST004988
699	EGFR	alvocidib	CDK inhibitor	Phase 2	RMM-GWAS	GCST004988
700	EGFR	AP26113	ALK tyrosine kinase receptor inhibitor	Phase 2	RMM-GWAS	GCST004988
701	EGFR	AST-1306	EGFR inhibitor	Phase 1	RMM-GWAS	GCST004988
702	EGFR	AV-412	protein tyrosine kinase inhibitor	Phase 1	RMM-GWAS	GCST004988
703	EGFR	AZD3759	EGFR inhibitor	Phase 2/Phase 3	RMM-GWAS	GCST004988
704	EGFR	AZD8931	EGFR inhibitor	Phase 2	RMM-GWAS	GCST004988
705	EGFR	AZ5104	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
706	EGFR	BIBU-1361	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
707	EGFR	BIBX-1382	EGFR inhibitor	Phase 1	RMM-GWAS	GCST004988
708	EGFR	BMS-599626	EGFR inhibitor|protein tyrosine kinase inhibitor	Phase 1	RMM-GWAS	GCST004988
709	EGFR	BMS-690514	EGFR inhibitor|VEGFR inhibitor	Phase 2	RMM-GWAS	GCST004988
710	EGFR	brigatinib	ALK tyrosine kinase receptor inhibitor|EGFR inhibitor	Launched	RMM-GWAS	GCST004988
711	EGFR	canertinib	EGFR inhibitor	Phase 3	RMM-GWAS	GCST004988
712	EGFR	CGP-52411	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
713	EGFR	CGP-53353	EGFR inhibitor|PKC inhibitor	Preclinical	RMM-GWAS	GCST004988
714	EGFR	chrysophanic-acid	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
715	EGFR	CNX-2006	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
716	EGFR	CUDC-101	EGFR inhibitor	Phase 1	RMM-GWAS	GCST004988
717	EGFR	dacomitinib	EGFR inhibitor	Launched	RMM-GWAS	GCST004988
718	EGFR	dovitinib	EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	Phase 3	RMM-GWAS	GCST004988
719	EGFR	EGF816	EGFR inhibitor	Phase 2	RMM-GWAS	GCST004988
720	EGFR	erbstatin-analog	EGFR inhibitor|tyrosine kinase inhibitor	Preclinical	RMM-GWAS	GCST004988
721	EGFR	erlotinib	EGFR inhibitor	Launched	RMM-GWAS	GCST004988
722	EGFR	gefitinib	EGFR inhibitor	Launched	RMM-GWAS	GCST004988
723	EGFR	GW-583340	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
724	EGFR	HKI-357	EGFR inhibitor	Phase 1	RMM-GWAS	GCST004988
725	EGFR	icotinib	EGFR inhibitor	Launched	RMM-GWAS	GCST004988
726	EGFR	lapatinib	EGFR inhibitor	Launched	RMM-GWAS	GCST004988
727	EGFR	lidocaine	histamine receptor agonist	Launched	RMM-GWAS	GCST004988
728	EGFR	mubritinib	protein tyrosine kinase inhibitor	Phase 1	RMM-GWAS	GCST004988
729	EGFR	neratinib	EGFR inhibitor	Launched	RMM-GWAS	GCST004988
730	EGFR	olmutinib	Bruton's tyrosine kinase (BTK) inhibitor|EGFR inhibitor	Launched	RMM-GWAS	GCST004988
731	EGFR	orantinib	FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	Phase 3	RMM-GWAS	GCST004988
732	EGFR	OSI-420	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
733	EGFR	osimertinib	EGFR inhibitor	Launched	RMM-GWAS	GCST004988
734	EGFR	PD-153035	EGFR inhibitor	Phase 1	RMM-GWAS	GCST004988
735	EGFR	PD-158780	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
736	EGFR	PD-166285	SRC inhibitor	Preclinical	RMM-GWAS	GCST004988
737	EGFR	PD-168393	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
738	EGFR	pelitinib	EGFR inhibitor	Phase 2	RMM-GWAS	GCST004988
739	EGFR	PKI-166	EGFR inhibitor	Phase 1	RMM-GWAS	GCST004988
740	EGFR	poziotinib	EGFR inhibitor	Phase 2	RMM-GWAS	GCST004988
741	EGFR	PP-121	protein tyrosine kinase inhibitor	Preclinical	RMM-GWAS	GCST004988
742	EGFR	rociletinib	EGFR inhibitor	Phase 3	RMM-GWAS	GCST004988
743	EGFR	tyrphostin-AG-1478	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
744	EGFR	tyrphostin-AG-18	EGFR inhibitor|tyrosine kinase inhibitor	Preclinical	RMM-GWAS	GCST004988
745	EGFR	tyrphostin-AG-494	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
746	EGFR	tyrphostin-AG-835	protein tyrosine kinase inhibitor	Preclinical	RMM-GWAS	GCST004988
747	EGFR	tyrphostin-AG-99	tyrosine kinase inhibitor	Preclinical	RMM-GWAS	GCST004988
748	EGFR	vandetanib	EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor	Launched	RMM-GWAS	GCST004988
749	EGFR	vatalanib	KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	Phase 3	RMM-GWAS	GCST004988
750	EGFR	WHI-P154	JAK inhibitor	Preclinical	RMM-GWAS	GCST004988
751	EGFR	WZ-3146	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
752	EGFR	WZ-4002	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
753	EGFR	WZ8040	EGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
754	EGFR	XL647	EGFR inhibitor|VEGFR inhibitor	Phase 3	RMM-GWAS	GCST004988
755	EGFR	ZM-306416	Abl kinase inhibitor|SRC inhibitor|VEGFR inhibitor	Preclinical	RMM-GWAS	GCST004988
756	TLR4	C34	toll-like receptor inhibitor	Preclinical	RMM-GWAS	GCST004748
757	TLR4	lauric-acid	bacterial permeability inducer	Phase 3	RMM-GWAS	GCST004748
758	TLR4	naloxone	opioid receptor antagonist	Launched	RMM-GWAS	GCST004748
759	TLR4	paclitaxel	tubulin polymerization inhibitor	Launched	RMM-GWAS	GCST004748
760	TLR4	resatorvid	toll-like receptor inhibitor	Phase 3	RMM-GWAS	GCST004748
761	TLR4	VGX-1027	tumor necrosis factor receptor antagonist	Phase 1	RMM-GWAS	GCST004748
762	IL6	andrographolide	tumor necrosis factor production inhibitor	Phase 2	RMM-GWAS	GCST009841
763	IL6	ibudilast	leukotriene receptor antagonist|phosphodiesterase inhibitor	Launched	RMM-GWAS	GCST009841
764	IL6	JTE-607	cytokine production inhibitor	Phase 2	RMM-GWAS	GCST009841
765	IL6	trofinetide	cytokine production inhibitor	Phase 2	RMM-GWAS	GCST009841
766	IL6	VX-702	p38 MAPK inhibitor	Phase 2	RMM-GWAS	GCST009841
767	ESR1	afimoxifene	estrogen receptor antagonist	Phase 2	SIGMOID	GCST004988
768	ESR1	allylestrenol	steroidal progestin	Launched	SIGMOID	GCST004988
769	ESR1	AZD9496	estrogen receptor agonist	Phase 1	SIGMOID	GCST004988
770	ESR1	bazedoxifene	selective estrogen receptor modulator (SERM)	Launched	SIGMOID	GCST004988
771	ESR1	benfluralin		Phase 3	SIGMOID	GCST004988
772	ESR1	bisphenol-A	synthetic estrogen	Phase 1	SIGMOID	GCST004988
773	ESR1	bithionol	autotaxin inhibitor	Withdrawn	SIGMOID	GCST004988
774	ESR1	chlorotrianisene	estrogenic hormone	Launched	SIGMOID	GCST004988
775	ESR1	clomifene	estrogen receptor antagonist	Launched	SIGMOID	GCST004988
776	ESR1	danazol	estrogen receptor antagonist|progesterone receptor agonist	Launched	SIGMOID	GCST004988
777	ESR1	dehydroepiandrosterone	protein synthesis stimulant	Launched	SIGMOID	GCST004988
778	ESR1	dehydroepiandrosterone-sulfate	androgen receptor agonist|estrogen receptor agonist	Launched	SIGMOID	GCST004988
779	ESR1	desogestrel	progesterone receptor agonist	Launched	SIGMOID	GCST004988
780	ESR1	dienestrol	estrogen receptor agonist	Launched	SIGMOID	GCST004988
781	ESR1	diethylstilbestrol	estrogen receptor agonist	Withdrawn	SIGMOID	GCST004988
782	ESR1	droloxifene	selective estrogen receptor modulator (SERM)	Phase 3	SIGMOID	GCST004988
783	ESR1	endoxifen	estrogen receptor antagonist	Phase 2	SIGMOID	GCST004988
784	ESR1	equol	estrogen receptor agonist	Launched	SIGMOID	GCST004988
785	ESR1	erteberel	estrogen receptor agonist	Phase 2	SIGMOID	GCST004988
786	ESR1	estetrol	selective estrogen receptor modulator (SERM)	Phase 3	SIGMOID	GCST004988
787	ESR1	estradiol	estrogen receptor agonist	Launched	SIGMOID	GCST004988
788	ESR1	estradiol-acetate	estrogen receptor agonist	Launched	SIGMOID	GCST004988
789	ESR1	estradiol-benzoate	contraceptive agent	Preclinical	SIGMOID	GCST004988
790	ESR1	estradiol-cypionate	estrogen receptor agonist	Launched	SIGMOID	GCST004988
791	ESR1	estradiol-valerate	estrogen receptor agonist	Launched	SIGMOID	GCST004988
792	ESR1	estramustine	DNA alkylating agent	Launched	SIGMOID	GCST004988
793	ESR1	estramustine-phosphate	DNA synthesis inhibitor|microtubule inhibitor	Launched	SIGMOID	GCST004988
794	ESR1	estriol	estrogen receptor agonist	Launched	SIGMOID	GCST004988
795	ESR1	estrone	estrogen receptor agonist|estrogenic hormone	Launched	SIGMOID	GCST004988
796	ESR1	estropipate	estrogen receptor agonist	Launched	SIGMOID	GCST004988
797	ESR1	ethinyl-estradiol	estrogen receptor agonist|estrogenic hormone	Launched	SIGMOID	GCST004988
798	ESR1	ethynodiol-diacetate		Launched	SIGMOID	GCST004988
799	ESR1	etonogestrel	progesterone receptor agonist	Launched	SIGMOID	GCST004988
800	ESR1	fosfestrol	synthetic estrogen	Launched	SIGMOID	GCST004988
801	ESR1	fulvestrant	estrogen receptor antagonist	Launched	SIGMOID	GCST004988
802	ESR1	GDC-0810	selective estrogen receptor destabilizer	Phase 2	SIGMOID	GCST004988
803	ESR1	genistein	tyrosine kinase inhibitor	Phase 2/Phase 3	SIGMOID	GCST004988
804	ESR1	gestrinone	progesterone receptor antagonist	Launched	SIGMOID	GCST004988
805	ESR1	hexestrol	synthetic estrogen	Launched	SIGMOID	GCST004988
806	ESR1	lasofoxifene	selective estrogen receptor modulator (SERM)	Launched	SIGMOID	GCST004988
807	ESR1	medroxyprogesterone-acetate	progesterone receptor agonist	Launched	SIGMOID	GCST004988
808	ESR1	melatonin	melatonin receptor agonist|nitric oxide synthase inhibitor	Launched	SIGMOID	GCST004988
809	ESR1	mestranol	estrogen receptor agonist	Launched	SIGMOID	GCST004988
810	ESR1	mitotane	antineoplastic agent	Launched	SIGMOID	GCST004988
811	ESR1	naloxone	opioid receptor antagonist	Launched	SIGMOID	GCST004988
812	ESR1	norgestimate	progesterone receptor agonist	Launched	SIGMOID	GCST004988
813	ESR1	norgestrel	progesterone receptor agonist	Launched	SIGMOID	GCST004988
814	ESR1	ospemifene	selective estrogen receptor modulator (SERM)	Launched	SIGMOID	GCST004988
815	ESR1	PPT	estrogen receptor agonist	Preclinical	SIGMOID	GCST004988
816	ESR1	progesterone	progesterone receptor agonist	Launched	SIGMOID	GCST004988
817	ESR1	promestriene	estrogen receptor agonist	Launched	SIGMOID	GCST004988
818	ESR1	quinestrol	estrogen receptor agonist	Launched	SIGMOID	GCST004988
819	ESR1	raloxifene	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	SIGMOID	GCST004988
820	ESR1	SNG-1153	selective estrogen receptor modulator (SERM)	Preclinical	SIGMOID	GCST004988
821	ESR1	tamoxifen	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	SIGMOID	GCST004988
822	ESR1	tibolone	androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist	Launched	SIGMOID	GCST004988
823	ESR1	toremifene	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	SIGMOID	GCST004988
824	ESR1	Y-134	estrogen receptor antagonist	Preclinical	SIGMOID	GCST004988
825	ESR1	ZK-164015	estrogen receptor antagonist	Preclinical	SIGMOID	GCST004988
826	ESR1	17-hydroxyprogesterone-caproate	progesterone receptor agonist	Launched	SIGMOID	GCST004988
